Key Specifications Table
Pricing & Availability
An invalid quantity was specified. The product quantity has been adjusted.
|476496-5MG||Glass bottle||5 mg||
|Overview||A cell-permeable, quinazoline analog that potently and selectively inhibits PKMT G9a (IC50 = 6 nM and 9 nM in two biochemical assays for CLOT and ECSD, respectively, and Ki = 63 pM, which is approximately 250-fold more potent than a closely-related analog, BIX01294 (Cat. No. 382190)). It inhibits GLP with reduced potency (15 nM) and is found to be inactive (IC50 > 40 µM) toward other protein lysine and arginine methyltransferases, such as SET7/9 (aH3K4 PKMT), SET8/PreSET7 (aH4K20 PKMT), and PRMT3, as well as JMJD2E (> 1000-fold selectivity) in ECSD enzymatic assays. It also inhibits H3K9me2 accumulation (IC50 = 11,000 nM) in MDA-MB-231 cells, in comparison to BIX01294 (IC50 = 500 nM).
Please note that the molecular weight for this compound is batch-specific due to variable water content.
|References||Liu, F., et al. 2010. J. Med. Chem. 53, 5844.|
|Form||Light tan solid|
|Structure formula Image|
|Purity||>98% by HPLC|
|Safety Information according to GHS|
|Product Usage Statements|
|Packaged under inert gas||Packaged under inert gas|
Protein Lysine Methyltransferase Inhibitor, UNC0321 - Calbiochem SDS
|Liu, F., et al. 2010. J. Med. Chem. 53, 5844.|